EDGAR Filing Documents for 0001213900-13-007037

Form 8-K - Current report:

SEC Accession No. 0001213900-13-007037

Filing Date

2013-12-06

Accepted

2013-12-06 12:55:06

Documents

Period of Report

2013-11-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	f8k111513_yewbiopharm.htm	8-K	38102
2	VALUATION OF THE FOREST AND LAND USE RIGHT FOR YEW BIO-PHARM GROUP, INC. AS OF O	f8k111513ex10i_yewbiopharm.htm	EX-10.1	286767
3	A FOREST AND LAND USE RIGHT ACQUISITION CONTRACT BETWEEN HARBIN YEW SCIENCE AND	f8k111513ex10ii_yewbiopharm.htm	EX-10.2	30118
4		img001.jpg	GRAPHIC	5179
5		img11.jpg	GRAPHIC	31585
6		img12.jpg	GRAPHIC	27663
	Complete submission text file	0001213900-13-007037.txt		445427

Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148

Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379

Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)